| Literature DB >> 34932344 |
Sander J Wezenberg1,2, Li-Jun Chen3, Jasper E Bos1, Ben L Feringa2, Ethan N W Howe3, Xin Wu3, Maxime A Siegler4, Philip A Gale3,5.
Abstract
Membrane transport proteins fulfill important regulatory functions in biology with a common trait being their ability to respond to stimuli in the environment. Various small-molecule receptors, capable of mediating transmembrane transport, have been successfully developed. However, to confer stimuli-responsiveness on them poses a fundamental challenge. Here we demonstrate photocontrol of transmembrane transport and electric potential using bis(thio)ureas derived from stiff-stilbene. UV-vis and 1H NMR spectroscopy are used to monitor E-Z photoisomerization of these bis(thio)ureas and 1H NMR titrations reveal stronger binding of chloride to the (Z)-form than to the (E)-form. Additional insight into the binding properties is provided by single crystal X-ray crystallographic analysis and DFT geometry optimization. Importantly, the (Z)-isomers are much more active in transmembrane transport than the respective (E)-isomers as shown through various assays. As a result, both membrane transport and depolarization can be modulated upon irradiation, opening up new prospects toward light-based therapeutics as well as physiological and optopharmacological tools for studying anion transport-associated diseases and to stimulate neuronal activity, respectively.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34932344 PMCID: PMC8759083 DOI: 10.1021/jacs.1c10034
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Scheme 1(a) Photoisomerization of Stiff-Stilbene Based Bis(thio)ureas and (b) Schematic Representation of Photocontrolled Transmembrane Transport
Figure 1UV–vis spectrum of (E)-1b in degassed DMSO (2.5 × 10–4 M) and spectra obtained upon 365 and 385 nm irradiation. The inset shows the absorption change (at 365 nm) upon multiple cycles.
Photoswitching, Chloride Binding, and Transport Properties of 1a–c and 2a–c
| Carrier | PSS365( | PSS385( | EC50( | EC50( | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 49:51 | 93:7 | 17 | 66 | 0.230 | 0.034 | 6.8 | 0.472 | >10 | >21.2 | |
| 65:35 | 93:7 | 21 | 107 | 0.398 | 0.036 | 11.1 | 0.057 | >10 | >175.4 | |
| n.d. | n.d. | n.d. | 103 | 1.187 | 0.035 | 33.9 | 0.018 | >10 | >568.8 | |
| 53:47 | 83:17 | 15 | 93 | 1.140 | 0.060 | 19.1 | 0.070 | 2.073 | 29.7 | |
| 53:47 | 74:26 | 18 | 125 | 0.433 | 0.034 | 12.8 | 0.160 | >10 | >62.5 | |
| 48:52 | 48:52 | 21 | 102 | 2.030 | 0.243 | 8.4 | 0.002 | 0.036 | 16.3 |
Microscopic constants (K1m( = K11/2, K1m( = K11) for the first chloride binding event determined by 1H NMR titrations using the tetrabutylammonium salt in DMSO-d6/0.5% H2O; errors are estimated to be no more than 15%.
Not determined because of poor solubility.
Initial rates of chloride transport (kini) obtained using HPTS assay for each transporter (1 mol %).
Factor of enhancement in the Cl– transport rate between (Z)-isomer and (E)-isomer (F( = kini(/kini().
EC50 defined as the effective concentration needed for 50% activity at t = 600 s; values reported in transporter to lipid molar ratio (mol %).
Poor transport activity prevented full Hill analysis.
Factor of enhancement in the Cl– transport activity between (Z)-isomer and (E)-isomer (F′( = EC50(/EC50().
When EC50 > 10, the EC50 value was considered as 10 in factor calculations.
Figure 2Displacement ellipsoid plot (50% probability level) of (M)-(Z)-1c⊂Cl– at 110(2) K. The tetrabutylammonium cation has been omitted for clarity.
Figure 3(a) Plots of chloride efflux against time (s) across POPC vesicles facilitated by (Z)-isomers (●, 1 mol % to lipid) and (E)-isomers (▲, 1 mol % to lipid). (b) Initial rate of chloride transport calculated by exponential or linear fit for each transporter. Detailed experimental conditions are presented in the Supporting Information. (c) Comparison of the concentration–activity curves between (Z)-1c and (E)-1c. The solid lines are the fitted curves from Hill equation. (d) Percent transport efficiencies of 365 nm irradiated samples of (E)-2a plotted relative to the activity of (Z)-2a.
Summary of Cl– Transport Activity and Cl– > H+/OH– Selectivity of (Z)-1a–c and (Z)-2a–c (EC50 Values Are Shown in Transporter-to-Lipid Molar Ratio (mol %))
| Carrier | EC50(BSA) | EC50 | EC50(BSA_FCCP) | EC50(FCCP) | |||
|---|---|---|---|---|---|---|---|
| ( | >10 | 0.472 | 0.035 | 0.077 | >21.2 | >283.7 | 6.1 |
| ( | >10 | 0.057 | 0.091 | 0.030 | >175.4 | >110.2 | 1.9 |
| ( | 0.137 | 0.018 | 0.141 | 0.016 | 7.8 | 1.0 | 1.1 |
| ( | 1.726 | 0.070 | 0.017 | 0.019 | 24.7 | 102.8 | 3.6 |
| ( | 0.703 | 0.160 | 0.360 | 0.155 | 4.4 | 2.0 | 1.0 |
| ( | 0.006 | 0.002 | 0.007 | 0.002 | 2.8 | 0.8 | 0.9 |
EC50 in the presence of BSA, showing the total Cl–/H+ symport without the presence of fatty acid.
EC50 in the presence of fatty acid, showing the effect of the natural acceleration of H+ transport facilitated by fatty acids on the overall transport process.
The same data as shown in Table .
EC50 in the presence of BSA and FCCP, showing the maximum Cl– uniport possible, since without FCCP, H+/OH– transport may be rate limiting.
EC50 in the presence FCCP, showing the maximum Cl– uniport possible in the presence of fatty acid.
Factor of enhancement in the overall rate of Cl–/H+ cotransport in the presence of fatty acid, FFA is calculated by dividing the EC50(BSA) by the EC50. FFA > 1 indicates the receptor can assist the flip-flop of fatty acid, increasing pH dissipation.
Factor of Cl– > H+/OH– selectivity, Fs is quantified by EC50(BSA) divided by EC50(BSA_FCCP), Fs > 1 indicates faster Cl– than H+/OH– transport, i.e. Cl– selective.
Factor of Cl–> H+/OH– selectivity retention in the presence of fatty acid, F′s is calculated by dividing the EC50 by the EC50(FCCP), F′s > 1 indicates Cl– selective retention in the presence of fatty acid.
Poor transport activity prevented full Hill analysis.
When EC50 > 10, considering the EC50 value as 10 in factor calculations.
Figure 4(a) Schematic representation of the Safranin O fluorescence assay. POPC vesicles were loaded with HEPES (10 mM) buffered KCl (100 mM) and suspended in HEPES (10 mM) buffered NaCl (100 mM) with Safranin O and adjusted to pH 7.0. Valinomycin was added to produce polarized liposomes. Once stable emission was observed, 5 μL of a DMSO solution of compound (1 mol % to lipid) was added. (b) The change in emission intensity of safranin O was monitored over time upon addition of (Z)-1a–c and (Z)-2a–c and (c) (E)-2a before and after 365 nm irradiation. (d) Depolarization efficiencies (%) of irradiated samples of (E)-2a relative to the activity of (Z)-2a.